查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
镇咳药物市场与 COVID-19 影响分析，按药物类别、按给药途径、按年龄组、按最终用户、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
市场调查报告书
商品编码
1339909

镇咳药物市场与 COVID-19 影响分析，按药物类别、按给药途径、按年龄组、按最终用户、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Antitussive Drugs Market with COVID-19 Impact Analysis, By Drug Class, By Route of Administration, By Age Group, By End-Users, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 238 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022年镇咳药物市场规模为14.083亿美元，2023年至2030年復合年增长率为5.1%。

镇咳药市场-市场动态：

  • 咳嗽病例的增加和老年人口的增加将促进市场增长。
  • 推动镇咳药物需求的主要因素是咳嗽，这将推动市场增长。此外，呼吸系统疾病的日益流行和大气污染的严重程度增加了个人咳嗽的病例。人们咳嗽和咳嗽的传染性是世界各地去看初级保健医生的最常见目的。因此，持续咳嗽会损害一个人的生活质量；镇咳药需求将稳步增长。然而，镇咳药物的高成本和发展中国家缺乏医疗基础设施预计将阻碍市场需求。此外，老年人口更容易患慢性病，预计这将加速市场的增长速度。因此，老年人口的增加预计将推动市场向前发展。

镇咳药物市场 - 主要见解：

  • 根据我们的研究分析师分享的分析，预计全球镇咳药物市场在预测期内（2023-2030）每年将以 5.1% 左右的复合年增长率增长
  • 由于呼吸道感染、过敏和慢性阻塞性肺病（COPD）等咳嗽相关疾病的广泛发生，镇咳药物行业一直在稳定增长。在流感和寒冷季节，镇咳药物的需求往往会激增。
  • 根据药物类别细分，预计中枢作用药物将在 2022 年展现出可观的市场份额
  • 一些镇咳药物与其他活性成分（例如减充血剂或祛痰剂）结合使用，可以全面缓解多种感冒和流感症状。

镇咳药市场-細項分析：

  • 全球镇咳药物市场根据药物类别、给药途径、年龄组、最终用户和地区进行细分。
  • 市场根据药物类别分为两类：外周作用药物、中枢作用药物和其他。中枢作用药物领域可能会在预测期内保持其主导地位。它通过针对咳嗽中枢在大脑中发挥作用，最大限度地减少咳嗽的衝动。此外，这些药物主要用于治疗不产生粘液的持续性干咳。推动市场的因素包括药物开发的进步、医疗保健政策的变化、呼吸系统疾病的流行以及消费者对非处方药或处方药的偏好。
  • 市场根据给药途径分为两类：吸入、口服和其他。口腔细分市场预计将占据最高的市场份额。它是指对更广泛的口服镇咳药物市场中特定细分市场的市场评估或分析，包括片剂、含片、糖浆和胶囊。
  • 市场根据年龄组分为三类：老年、儿童和成人。预计老年医学领域将快速增长。老年人口一词是指 65 岁及以上的个体。该人群具有特殊的医疗保健需求和特征，这对製药和医疗保健等多个行业都有影响。
  • 市场根据最终用户分为三类：家庭护理、医院、专科诊所等。专科诊所部门可能拥有最大的市场份额。该部门专注于选择性医学专业，包括呼吸和肺病学医学。这些诊所通常从事与呼吸系统疾病相关的临床试验和研究。此外，这将有助于新镇咳药物的测试和开发。

镇咳药物市场-地理洞察：

从地域上看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

镇咳药市场-竞争格局：

这些药物的易获得性和认知度的提高将为市场增长提供优势。此外，随着公共和私人组织采取主动传播意识，镇咳药物市场将会蓬勃发展。上呼吸道感染病例的增加和可支配收入的增加将导致镇咳药物业务的扩张。研发活动数量的增加将提供有利的机会，而药物上市和批准的增加将进一步推动市场的增长率。例如，2021 年3 月，默克公司宣布，美国食品和药物管理局(FDA) 已就默克公司的新药申请(NDA) 发出完整回应函(CRL)，该申请是一种在研口服选择性P2X3 受体拮抗剂，非-正在开髮用于不明原因慢性咳嗽（UCC）或治疗成人难治性慢性咳嗽（RCC）的麻醉剂，以讨论下一步。

最近的发展：

例如，2021年9月，太阳製药工业有限公司在印度推出了一种治疗咳嗽的新型製剂——Chericof 12（马来酸氯苯那敏4毫克或氢溴酸右美沙芬30毫克）。

该研究的主要特点：

  • 这项关于镇咳药物市场的拟议研究提供了市场规模（百万美元）、年复合成长率（CAGR%）和预测估计（2023-2030年），以2022年为基准年。
  • 该报告为客户提供了有关镇咳药物市场的最新动态和趋势见解。
  • 该研究报告阐明了不同细分市场/国家的潜在增长机会，并解释了镇咳药物市场有吸引力的投资主张矩阵。
  • 总体报告确定了新的投资机会、老牌参与者面临的挑战以及维持镇咳药物市场的增长因素。
  • 研究范围详细讨论了 COVID-19 对镇咳药物市场规模、预测、复合年增长率和市场动态的影响。还将详细介绍新冠疫情后镇咳药物市场的情况。
  • 为了让本报告的用户全面了解镇咳药物市场，我们还包括了镇咳药物市场的竞争格局和关键创新者分析。
  • 该研究包括增长前景映射分析，其中所有行业细分都根据其市场规模、增长率和吸引力进行基准测试。
  • 该报告提供了主要市场参与者的详细公司概况，这些参与者将帮助用户了解镇咳药物市场参与者的财务信息和战略倡议。
  • 此外，报告还揭示了全球和区域市场主要参与者的重要收购和兼併、合作和合资、新产品推出、研发、区域扩张。
  • 全球镇咳药物市场报告主要面向该行业的各个利益相关者，包括供应商、投资者、新进入者、分销商和财务分析师。

目录

第 1 章：镇咳药市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按药物类别分類的镇咳药物市场片段
    • 按给药途径分類的镇咳药物市场片段
    • 按年龄段分類的镇咳药物市场片段
    • 最终用户的镇咳药物市场片段
    • 按国家/地区分類的镇咳药物市场片段
    • 按地区分類的镇咳药市场片段
  • 竞争洞察

第 3 章：镇咳药物主要市场趋势

  • 镇咳药市场驱动因素
    • 市场驱动因素的影响分析
  • 镇咳药市场限制
    • 市场限制影响分析
  • 镇咳药市场机会
  • 镇咳药市场未来趋势

第 4 章：镇咳药行业研究

  • PEST分析
  • 波特五力分析
  • 增长前景图
  • 规范架构分析

第 5 章：镇咳药物市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的细分市场
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：镇咳药市场格局

  • 2022 年镇咳药市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：镇咳药物市场 - 按药物类别

  • 概述
    • 按药物类别分類的细分市场份额分析
    • 外周作用药物
    • 中枢作用药物
    • 其他的

第 8 章：镇咳药物市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市场份额分析
    • 吸入式
    • 口服
    • 其他的

第 9 章：镇咳药物市场 - 按年龄组

  • 概述
    • 按年龄组分類的细分市场份额分析
    • 老年科
    • 儿科
    • 成人

第 10 章：镇咳药物市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场份额分析
    • 家庭护理
    • 医院
    • 专科诊所
    • 其他的

第 11 章：镇咳药物市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场份额分析
  • 北美
    • 概述
    • 北美镇咳药物主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按药物类别）
    • 北美市场规模和预测（按管理途径）
    • 北美市场规模和预测（按年龄组）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲镇咳药物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按药物类别）
    • 欧洲市场规模和预测（按管理途径）
    • 欧洲市场规模和预测（按年龄段）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 意大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区镇咳药主要製造商
    • 亚太地区市场规模和预测（按国家）
    • 亚太地区市场规模和预测（按药物类别）
    • 亚太地区市场规模和预测（按管理途径）
    • 亚太地区市场规模和预测（按年龄组）
    • 亚太地区最终用户市场规模和预测
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳大利亚
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉美
    • 概述
    • 拉丁美洲镇咳药物主要製造商
    • 拉丁美洲市场规模和预测（按国家）
    • 拉丁美洲市场规模和预测（按药物类别）
    • 拉丁美洲市场规模和预测（按管理途径）
    • 拉丁美洲市场规模和预测（按年龄组）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲镇咳药主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按药物类别）
    • 中东和非洲市场规模及预测（按管理途径）
    • 中东和非洲市场规模及预测（按年龄组）
    • 中东和非洲市场规模和预测（按最终用户）
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 以色列
    • 火鸡
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析-止咳药行业

  • 竞争仪表板
  • 公司简介
    • Teva Pharmaceutical Industries Ltd.
    • Intas Pharmaceuticals Ltd.
    • Bayer AG
    • Aceto
    • Sanofi
    • Ipca Laboratories Ltd.
    • 3M
    • F. Hoffmann-La Roche Ltd.
    • Hikma Pharmaceuticals PLC
    • Unique Pharmaceuticals Limited
    • Cipla Inc.
    • Mylan NV
    • Zydus Cadila
    • Sanofi
    • Novartis AG
    • Aurobindo Pharma

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联繫我们
Product Code: ANV1633

REPORT HIGHLIGHT

Antitussive drugs market size was valued at USD 1,408.3 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Antitussive drugs are defined as heterogeneous medications commonly used in patients suffering from respiratory disorders to suppress dry cough. In addition, various symptoms caused by common allergies, colds, flu, hay fever, or other breathing disorders like bronchitis and sinusitis can be treated by antitussive drugs. These drugs act on the cough center in the brain to reduce the urge to cough in patients. They are either opioids or opiates such as dextromethorphan, pholcodine, and codeine. Moreover, one of the commonly used drugs is dextromethorphan over-the-counter antitussive drugs, and it is relatively safe.

Antitussive Drugs Market- Market Dynamics:

  • Rising cough cases and the geriatric population will augment the market growth.
  • The major element boosting demand for antitussive drugs is cough, which will drive the market growth. In addition, the growing prevalence of respiratory disorders and the high rate of atmospheric pollution increase the cases of cough in individuals. The contagious nature of people's coughs and coughs is the most common purpose to visit primary care physicians across the world. Thus, persistent cough can harm a person's quality of life; the demand for antitussive drugs will witness steady growth. However, the high cost of antitussive drugs and the lack of healthcare infrastructure in developing nations are expected to hamper the market demand. Furthermore, the older population is more prone to chronic disease, which is anticipated to accelerate the market's growth rate. Thus, the rise in the geriatric population will be projected to drive the market forward.

Antitussive Drugs Market- Key Insights:

  • As per the analysis shared by our research analyst, the global antitussive drugs market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)
  • The antitussive drugs industry has been witnessing steady growth due to the widespread occurrence of cough-related conditions, including respiratory infections, allergies, and chronic obstructive pulmonary disease (COPD). The demand for antitussive medications tends to spike during flu and cold seasons.
  • Based on drug class form segmentation, Centrally Acting Drugs was predicted to show promising market share in the year 2022
  • Some antitussive medications are combined with other active ingredients, such as decongestants or expectorants, to provide comprehensive relief from multiple cold and flu symptoms.

Antitussive Drugs Market- Segmentation Analysis:

  • The Global antitussive drugs market is segmented on the basis of drug class, route of administration, age group, end-users, and region.
  • The market is divided into two categories based on drug class: peripherally acting drugs, centrally acting drugs, and others. The centrally acting drugs segment is likely to maintain its dominance over the forecast period. It works in the brain by targeting the cough center, minimizing the urge to cough. Additionally, these medications are mostly preferred to treat persistent dry coughs that don't produce mucus. The factors propelling the market include advances in drug development, changes in healthcare policies, the prevalence of respiratory conditions, and consumer preferences for over-the-counter or prescription medications.
  • The market is divided into two categories based on the route of administration: inhalational, oral, and others. The oral segment is expected to hold the highest market share. It refers to a market assessment or analysis of a particular segment within the broader antitussive drugs market which are administered orally including tablets, lozenges, syrups, and capsules.
  • The market is divided into three categories based on age group: geriatric, pediatric, and adult. The geriatric segment is anticipated to witness speedy growth. The term geriatric population refers to individuals 65 and older. This population has special healthcare needs and traits that have implications for several industries, such as pharmaceuticals and healthcare.
  • The market is divided into three categories based on end-users: homecare, hospitals, specialty clinics, and others. The specialty clinics segment is likely to possess the largest market share. The segment focuses on selective medical specialties, including respiratory and pulmonology medicine. The clinics commonly engaged in clinical trials and research related to respiratory diseases. Additionally, this will assist in the testing and development of new antitussive drugs.

Antitussive Drugs Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antitussive Drugs Market- Competitive Landscape:

Easy availability and rising awareness of these drugs will offer advantages for market growth. Moreover, the antitussive drugs market will boost as public and private organizations take initiatives to spread awareness. Rising infection cases of the upper respiratory tract and high disposable income will result in the expansion of the antitussive drugs business. An increase in the number of research and development activities will provide beneficial opportunities as well as rising drug launches and approvals will further propel the market's growth rate. For instance, in March 2021, Merck announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Merck's New Drug Application (NDA) for gefapixant, the investigational, orally administered selective P2X3 receptor antagonist, non-narcotic under development for the unexplained chronic cough (UCC) or treatment of refractory chronic cough (RCC) in adults agency to discuss the next steps.

Recent Developments:

For instance, in September 2021, Sun Pharmaceutical Industries Ltd. launched of a novel formulation in cough management - Chericof 12 (chlorpheniramine maleate 4 mg or dextromethorphan hydrobromide 30 mg) in India.

Key features of the study:

  • This proposed research study on antitussive drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the antitussive drugs market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for antitussive drugs market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the antitussive drugs market.
  • Impact of COVID-19 on antitussive drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on antitussive drugs market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the antitussive drugs market, we have also included competitive landscape and key innovator analysis for the antitussive drugs market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the antitussive drugs market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global antitussive drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTITUSSIVE DRUGS MARKET KEY PLAYERS

  • Teva Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Bayer AG
  • Aceto
  • Sanofi
  • Ipca Laboratories Ltd.
  • 3M
  • F. Hoffmann-La Roche Ltd.
  • Hikma Pharmaceuticals PLC
  • Unique Pharmaceuticals Limited
  • Cipla Inc.
  • Mylan N.V.
  • Zydus Cadila
  • Sanofi
  • Novartis AG
  • Aurobindo Pharma

GLOBAL ANTITUSSIVE DRUGS MARKET, BY DRUG CLASS

  • Peripherally Acting Drugs
  • Centrally Acting Drugs
  • Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY ROUTE OF ADMINISTRATION

  • Inhalational
  • Oral
  • Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY AGE GROUP

  • Geriatric
  • Pediatric
  • Adult

GLOBAL ANTITUSSIVE DRUGS MARKET, BY END-USERS

  • Homecare
  • Hospitals
  • Specialty Clinics
  • Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antitussive Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antitussive Drugs Market Snippet by Drug Class
    • 2.1.2. Antitussive Drugs Market Snippet by Route of Administration
    • 2.1.3. Antitussive Drugs Market Snippet by Age Group
    • 2.1.4. Antitussive Drugs Market Snippet by End-Users
    • 2.1.5. Antitussive Drugs Market Snippet by Country
    • 2.1.6. Antitussive Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Antitussive Drugs Key Market Trends

  • 3.1. Antitussive Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antitussive Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antitussive Drugs Market Opportunities
  • 3.4. Antitussive Drugs Market Future Trends

4. Antitussive Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antitussive Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Antitussive Drugs Market Landscape

  • 6.1. Antitussive Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antitussive Drugs Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022&2030 (%)
    • 7.1.2. Peripherally Acting Drugs
    • 7.1.3. Centrally Acting Drugs
    • 7.1.4. Others

8. Antitussive Drugs Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
    • 8.1.2. Inhalational
    • 8.1.3. Oral
    • 8.1.4. Others

9. Antitussive Drugs Market - By Age Group

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Age Group, 2022&2030 (%)
    • 9.1.2. Geriatric
    • 9.1.3. Pediatric
    • 9.1.4. Adult

10. Antitussive Drugs Market - By End-Users

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Users, 2022&2030 (%)
    • 10.1.2. Homecare
    • 10.1.3. Hospitals
    • 10.1.4. Specialty Clinics
    • 10.1.5. Others

11. Antitussive Drugs Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Antitussive Drugs Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Antitussive Drugs Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Antitussive Drugs Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Antitussive Drugs Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Antitussive Drugs Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Antitussive Drugs Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Teva Pharmaceutical Industries Ltd.
    • 12.2.2. Intas Pharmaceuticals Ltd.
    • 12.2.3. Bayer AG
    • 12.2.4. Aceto
    • 12.2.5. Sanofi
    • 12.2.6. Ipca Laboratories Ltd.
    • 12.2.7. 3M
    • 12.2.8. F. Hoffmann-La Roche Ltd.
    • 12.2.9. Hikma Pharmaceuticals PLC
    • 12.2.10. Unique Pharmaceuticals Limited
    • 12.2.11. Cipla Inc.
    • 12.2.12. Mylan N.V.
    • 12.2.13. Zydus Cadila
    • 12.2.14. Sanofi
    • 12.2.15. Novartis AG
    • 12.2.16. Aurobindo Pharma

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Antitussive Drugs Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Antitussive Drugs Market, by Drug Class2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: Route of AdministrationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Antitussive Drugs Market, by Route of Administration2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: Age Group Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Age Group
  • TABLE Global Antitussive Drugs Market, by Age Group 2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: End-Users Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-Users
  • TABLE Global Antitussive Drugs Market, by End-Users 2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Antitussive Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)

List of Figures

  • FIGURE Antitussive Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Class segment market share analysis, 2022&2030
  • FIGURE Drug Class segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022&2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Age Group segment market share analysis, 2022&2030
  • FIGURE Age Groupsegment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-Users segment market share analysis, 2022&2030
  • FIGURE End-Users segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Antitussive Drugs Market share and leading players, 2022
  • FIGURE Europe Antitussive Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Antitussive Drugs Market share and leading players, 2022
  • FIGURE Latin America Antitussive Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Antitussive Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Antitussive Drugs Market share analysis by country, 2022
  • FIGURE Germany Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Antitussive Drugs Market share analysis by country, 2022
  • FIGURE India Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antitussive Drugs Market share analysis by country, 2022
  • FIGURE Brazil Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antitussive Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)